News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

FDA Panel Rejects Novartis AG (NVS) Drug for Gout



6/21/2011 3:02:01 PM

A U.S. advisory panel on Tuesday rejected a Novartis AG drug for gout over concerns about side effects, a setback for the company's efforts to expand use of the medicine.

A committee of Food and Drug Administration advisers voted 11-1 against recommending approval of Ilaris for treating gout attacks. The panel also voted 12-0 against Ilaris for delaying and reducing the frequency of future attacks.

Read at Reuters
Read at Wall Street Journal
Read at MedPageToday


comments powered by Disqus
   
Gout

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES